Vanderbilt University Medical Center
Nashville, TN, United States
Have been faculty at Vanderbilt - since 2014. Currently the Lupus clinic director At Vanderbilt and direct the Lupus clinic trials. Fellowship program director since 2019.
Interested in patient-reported outcomes in Lupus.
Integrative Rheumatoid Arthritis Treatment Guidelines
Saturday, April 13, 2024
10:30 AM – 11:10 AM Central Time
Disclosure(s): AURINIA: Advisor or Review Panel Member (Terminated, August 10, 2023); GlaxoSmithKlein(GSK): Consultant (Ongoing); Novartis: Advisor or Review Panel Member (Terminated, July 29, 2022)
Saturday, April 13, 2024
10:55 AM – 11:10 AM Central Time
Disclosure(s): AURINIA: Advisor or Review Panel Member (Terminated, August 10, 2023); GlaxoSmithKlein(GSK): Consultant (Ongoing); Novartis: Advisor or Review Panel Member (Terminated, July 29, 2022)
Challenging Cases in RA: Joints and Beyond
Saturday, April 13, 2024
11:10 AM – 11:50 AM Central Time
Disclosure(s): AURINIA: Advisor or Review Panel Member (Terminated, August 10, 2023); GlaxoSmithKlein(GSK): Consultant (Ongoing); Novartis: Advisor or Review Panel Member (Terminated, July 29, 2022)
Saturday, April 13, 2024
11:35 AM – 11:50 AM Central Time
Disclosure(s): AURINIA: Advisor or Review Panel Member (Terminated, August 10, 2023); GlaxoSmithKlein(GSK): Consultant (Ongoing); Novartis: Advisor or Review Panel Member (Terminated, July 29, 2022)
Digital Ischemia for the Rheumatologist
Sunday, April 14, 2024
9:55 AM – 10:30 AM Central Time
Disclosure(s): AURINIA: Advisor or Review Panel Member (Terminated, August 10, 2023); GlaxoSmithKlein(GSK): Consultant (Ongoing); Novartis: Advisor or Review Panel Member (Terminated, July 29, 2022)
Sunday, April 14, 2024
10:20 AM – 10:30 AM Central Time
Disclosure(s): AURINIA: Advisor or Review Panel Member (Terminated, August 10, 2023); GlaxoSmithKlein(GSK): Consultant (Ongoing); Novartis: Advisor or Review Panel Member (Terminated, July 29, 2022)
